In 2000 and 2001, gene expression analysis led to the identification of IBC molecular subtypes, namely Luminal subtypes, HER2-enriched, Basal-like, and normal breast-like [9,10,11]. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.